£3.5M
The Leeds spinout secured backing led by Northern Gritstone to prepare its microfluidic device for human trials.
"At IVFmicro, we are harnessing years of research into reproductive biology to create a practical, accessible solution that can improve outcomes for patients undergoing fertility treatment. Our goal is to make IVF more effective, more predictable, and ultimately more hopeful for those striving to start a family."